BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/6/2026 6:30:43 AM | Browse: 0 | Download: 0
 |
Received |
|
2025-11-06 14:01 |
|
Peer-Review Started |
|
2025-11-06 14:01 |
|
First Decision by Editorial Office Director |
|
2025-12-09 07:21 |
|
Return for Revision |
|
2025-12-09 08:17 |
|
Revised |
|
2025-12-11 20:33 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-01-14 02:38 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-01-14 08:28 |
|
Articles in Press |
|
2026-01-14 08:28 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-01-26 10:31 |
|
Publish the Manuscript Online |
|
2026-02-06 06:30 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Cancer stem cell markers, chemotherapy response, and survival in triple-negative breast cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Faisal Nabi Depar, Ahmed Jamal Chaudhary, Jawad Hameed, Faisal Sarwar Abbasi, BiBi Uzma, Amjad Ali, Naheed Akhtar, Rizwan Khan, Afsheen Siddiqi and Sohail Riaz |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Sohail Riaz, MD, Department of Medicine, International University of Kyrgyzstan, International School of Medicine, 6 Seven April Street, Bishkek 720054, Kyrgyzstan. sohailriaz552@gmail.com |
| Key Words |
Triple-negative breast cancer; Cancer stem cells; CD44; CD24; Aldehyde dehydrogenase 1; Chemotherapy response; Survival; Pakistan |
| Core Tip |
In a Pakistani triple-negative breast cancer cohort, the cancer stem cell phenotype (CD44 high/CD24 low/aldehyde dehydrogenase 1 positive) occurred in 10.2% of cases and independently predicted markedly lower pathological complete response (5.0% vs 51.8%) and shorter overall survival (hazard ratio = 4.35). These findings from a South Asian population with high triple-negative breast cancer burden support cancer stem cell marker integration into risk stratification for personalized therapy in resource-limited settings. |
| Publish Date |
2026-02-06 06:30 |
| Citation |
Depar FN, Chaudhary AJ, Hameed J, Abbasi FS, Uzma B, Ali A, Akhtar N, Khan R, Siddiqi A, Riaz S. Cancer stem cell markers, chemotherapy response, and survival in triple-negative breast cancer. World J Clin Oncol 2026; 17(2): 116251 |
| URL |
https://www.wjgnet.com/2218-4333/full/v17/i2/116251.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v17.i2.116251 |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
